At the cellular level, cells infected with human immunodeficiency virus type 1 (HIV-1) exhibit immunity to a second infection by the virus that initiated the first infection or by related viruses [superinfection resistance (SIR)]. In the case of HIV infection, SIR was basically attributed to downregulation of the CD4 receptors. We have recently reported on an interaction between HIV-1 Rev and integrase (IN) proteins, which results in inhibition of IN activity in vitro and integration of cDNA in HIV-1-infected cells. A novel function for the viral Rev protein in controlling integration of HIV cDNAs was thus proposed. The results of the present work suggest involvement of the inhibitory Rev in sustaining SIR. A single exposure to wild-type HIV-1 resulted in one to two integrations per cell. The number of integrated proviral cDNA copies remained at this low level even after double infection or superinfection. SIR was dependent on Rev expression by the strain used for the first infection and was eliminated by peptides that disrupt intracellular complex formation between IN and Rev. The same lack of resistance was observed in the absence of Rev, namely following first infection with a DRev HIV strain. The involvement of Rev, expressed from either unintegrated or integrated viral cDNA, in promoting SIR was clearly demonstrated. We conclude that SIR involves Rev-dependent control of HIV cDNA integration.
INTRODUCTION
Various observations have indicated that human immunodeficiency virus (HIV) infection can indeed confer resistance, at the cellular level, to a second infection. Evidently, such resistance is mediated by mechanisms other than classical adaptive immune responses (Nethe et al., 2005; Piantadosi et al., 2007; Yeh et al., 2009) . The capacity to prevent a second infection, at the cellular level, by a virus that is closely related to that which established the first infection has been termed superinfection resistance (SIR) (Nethe et al., 2005; van der Kuyl & Cornelissen, 2007) . Although the molecular details of this mechanism have not yet been completely elucidated, it appears that in most cases it requires the expression of viral proteins (Nethe et al., 2005; Potash & Volsky, 1998) . Downregulation of CD4 from membranes of HIV-1-infected cells has been suggested to play a major role in conferring resistance to a second infection, but this mechanism is still under dispute (Potash & Volsky, 1998; Saha et al., 1999) . To date, the viral proteins Nef, as well as Vpu and Env, have been suggested to mediate downregulation of CD4 and thus to play an important role in conferring SIR (Wildum et al., 2006) . However, kinetic studies of CD4 downregulation in infected cells have raised doubt as to the relevance of this process to SIR (Potash & Volsky, 1998; Volsky et al., 1996) . Furthermore, it appears that CD4 downregulation increases virus replication and promotes release of new virions, indicating stimulation of virus production rather than resistance (Glushakova et al., 2001; Levesque et al., 2003) . Several studies have clearly demonstrated that no direct relations exist between SIR and CD4 downregulation (Potash & Volsky, 1998; Saha et al., 1999; Volsky et al., 1996) . Even assuming that downregulation of CD4 contributes to the development of SIR, the possibility of additional, CD4-independent mechanisms cannot be excluded and have, in fact, been suggested (Potash & Volsky, 1998; Wildum et al., 2006 Similar to Nef, the Rev protein is present in the early phase of infection, expressed from unintegrated viral cDNA (Iyer et al., 2009; Kelly et al., 2008; Wu, 2004 Wu, , 2008 Wu & Marsh, 2003) . The late viral Rev encoded by the integrated HIV genome has so far been implicated mainly in promoting nuclear export of unspliced and single-spliced transcripts (Pollard & Malim, 1998) . We have recently demonstrated that interaction between the viral Rev and integrase (IN) proteins results in inhibition of IN activity in vitro and integration of cDNA in HIV-1-infected cells (Levin et al., 2009a (Levin et al., , b, 2010b Rosenbluh et al., 2007) . Here, we provide the first demonstration of a novel function of Rev, namely a major and important role in conferring SIR, probably via its interaction with viral IN. HIV infection of cultured cells was quantitatively monitored by estimating integration levels of viral cDNA. About the same integration levels, 1.5-2.0 integrations per cell, were obtained following single or multiple infections with wild-type (wt) HIV-1, indicating the establishment of SIR (see also Levin et al., 2009a) . However, in the absence of Rev a significant increase in integration levels, i.e. eradication of resistance, was observed, proving the involvement of Rev in conferring SIR.
RESULTS

SIR can be promoted by Rev expressed from unintegrated cDNA
Infection with an HIV mutant (IN D64,116N HIV; INm), being unable to promote genome integration (Nakajima et al., 2001) , did not result in any viral DNA integration [ Fig. 1a(i) ]. However, infection with the wt HIV resulted in a relatively low degree of integration: 1.0-1.8 integrations per cell [ Fig. 1a (i) and see Butler et al., 2001; Levin et al., 2009a] . Infection with both viruses leads to the appearance of unintegrated viral cDNA which promotes the expression of several viral proteins, among them Rev (Iyer et al., 2009; Kelly et al., 2008; Wu, 2004 Wu, , 2008 Wu & Marsh, 2003 and Fig. 1b) . Indeed, Rev could clearly be observed at 8 h postinfection (p.i.) with both viruses, well before integration occurs (Fig. 1b and Iyer et al., 2009; Levin et al., 2009a) . Rev expressed by the INm cDNA was gradually eradicated and completely disappeared by 72 h p.i. (Fig. 1b) due to the dilapidation of unintegrated cDNA (Fig. 1c) . On the other hand, due to integration of the wt viral DNA, the amount of Rev expressed by the integrated cDNA gradually increased, reaching a maximum level by 72 h p.i. (Fig. 1b) .
Rev expressed by the unintegrated viral DNA was designated Rev-early (Rev-ear).
In the experiment described in Fig. 1a (ii), infection at zero time (1st-INF) was conducted with the INm HIV-1 (m.o.i.51) and then at the indicated times, cells were secondly infected (2nd-INF) with wt or VSV-g-coated virus (at an m.o.i.51 or 10) [ Fig. 1a(ii) ]. About 1.0-1.8 and 0.4-1.0 integrations per cell were obtained when the 2nd-INF was conducted 2 and 4 h after the 1st-INF, respectively. This must be due to the integration performed by the active viral IN, which was applied by the 2nd-INF. In practice, similar levels of integration were also obtained when the 2nd-INF with the wt or VSV-g-coated viruses was conducted from 60 h post-1st-INF on. At this time, most of the 1st-INF INm viral cDNA had already been abolished (Fig. 1c) and therefore no Rev expressed from the unintegrated cDNA of the INm (Rev-ear-INm) is present (Fig. 1b) . Due to the absence of the 1st-INF viral cDNA at this time, infection at 60 h and above can be considered identical to a single infection [ Fig. 1a (i) and see Levin et al., 2009a, b] . It should be noted that also infection by wt virus is expected to lead to the appearance of Rev-ear molecules expressed from unintegrated cDNA.
No integration, i.e. complete resistance to the 2nd-INF, was observed when the 2nd-INF was conducted between 8 and 48 h after the 1st-INF [ Fig. 1a(ii) ]. This was observed when the 2nd-INF was performed at an m.o.i.510 with either wt or VSV-g-coated viruses [ Fig. 1 a(ii) ]. These results confirm previous observations regarding complete resistance to 2nd-INF 24 h post-1st-INF with HIV-1 at an m.o.i.51 (Volsky et al., 1996) . The involvement of Rev-ear in promoting complete resistance to infection by wt or VSVg-coated HIV can be inferred from the results depicted in Fig. 1(d, e) . As can be seen [ Fig. 1d (ii)], stimulation of integration, namely eradication of resistance to the 2nd-INF, could be achieved by the addition of the IN-derived (INr) peptides, which promote disruption of the Rev-IN interaction ( Fig. 1e and see also Levin et al., 2009b) . This indicates that the observed resistance, namely inhibition of integration, was promoted by the presence of Rev molecules. Stimulation of integration promoted by the INr peptides (INrs) was also observed following a single infection [ Fig. 1d(i) ], or even when the 2nd-INF was performed between 4 and 60 h after the 1st-INF when SIR was observed [ Fig. 1d(ii) ]. This supports the view that the low level of integration obtained during these periods is also due to inhibition by Rev (Levin et al., 2009a (Levin et al., , 2010b . The question of whether a correlation exists between promotion of resistance and expression of Rev-ear (expressed by the unintegrated cDNA) could also be studied following the use of DRev HIV for the 2nd-INF. The results in Fig. 2(a) show that even under these conditions -namely, no expression of Rev following the 2nd-INF -complete resistance was obtained when infection was conducted at an m.o.i.51 or 10 of DRev HIV, but only between 12 and 36 h after the 1st-INF [ Fig. 2a(ii) ]. This indicates that at these time periods the Rev expressed following 1st-INF with INm HIV at an m.o.i.51 is sufficient to neutralize the relatively high amounts of IN molecule delivered following the 2nd-INF with as much as an m.o.i.510. A low level of integration, namely less resistance, was obtained when cells were secondly infected by the DRev VSV-g-coated virus at an m.o.i.510 -rather than with wt virus -whose infection is CD4-independent ( Fig. 2a and Matlin et al., 1982) . This suggests a minor contribution of CD4 downregulation to the resistance observed following 2nd-INF with wt HIV.
The view that the observed resistance is dependent on the quantitative relations between the titre of the first and second infected viruses is evident from the results depicted in Fig (Fig. 4) .
In the complete absence of Rev, only partial resistance is exerted due to CD4 downregulation It was of interest to determine the level of resistance obtained following double infection with DRev viruses, i.e. in the complete absence of Rev. As can be seen (compare results in Fig. 3 to Fig. 2a ) relatively high number of integrations per cell was observed when the 1st-INF and the 2nd-INF were conducted with DRev viruses. Absolutely no resistance was observed following 2nd-INF with the DRev VSV-g-coated virus, again indicating the involvement of Rev in conferring resistance to the 2nd-INF (Fig. 3) . However, a 50 % decrease in integration level was obtained from 12 h after the 1st-INF when the 2nd-INF was conducted with the wt-coated (bearing the wt env protein) DRev virus. In the absence of Rev, this partial resistance was probably due to CD4 downregulation or occupancy of the CD4 receptors, which mediate entry of the wt but not the VSV-g-coated viruses (Matlin et al., 1982) .
Promotion of SIR by double infection with wt HIV-1
Rev plays a major role in conferring SIR, even when the double infection was conducted with wt HIV. When the 2nd-INF was conducted 2 h after the 1st-INF (double infection), both with the wt HIV, about 1.2-1.7 integrations per cell were observed [ Fig. 5a(i) ]. A slightly lower degree of integration was obtained when the 2nd-INF was performed between 4 and 288 h after the 1st-INF [ Fig.  5a (ii)]. These integration levels were practically identical to those observed following a single infection with HIV-1 at an m.o.i. ranging from 1 to 10 [ Fig. 5a(i) ]. It was well established that integration of wt HIV cDNA should be completed between 16 and 20 h p.i. (Levin et al., 2009b; Pannecouque et al., 2002) . Interestingly, the level of integration observed from 16 to 288 h after the 1st-INF was very close or identical to that observed following a single infection [compare Fig. 5a (ii) to 5a(i) and Fig.  1a (ii)]. It can therefore be presumed that the cDNA from the 2nd-INF failed to integrate, indicating complete resistance to the second infection, at least between 16 and 288 h post-1st-INF. Since the levels of integration observed following the 2nd-INF between 4 and 12 h post1st-INF are very close or identical to those obtained at later times of 2nd-INF (Fig. 5a ). At these periods, the observed integration is also merely that of the 1st-INF cDNA. Based on the previously described results (Figs 1-3) , it is our assumption that the observed SIR is due to the presence of Rev-ear and Rev expressed by the integrated cDNA (Rev-late).
Essentially the same results, namely resistance to a 2nd-INF, were obtained when CD4-deficient cells were superinfected with the VSV-g-coated viruses ( Supplementary  Fig. S3 , available in JGV Online). Thus, these results suggest that the CD4 receptors are not involved in conferring resistance to the 2nd-INF. Dissociation of the intracellular Rev-IN complex by the INr peptides, resulted in significant stimulation of integration and clearly indicating involvement of Rev in promoting SIR ( Supplementary Fig. S4 , available in JGV Online).
Promotion of resistance was also observed when the 1st-INF was conducted with the wt virus and the 2nd-INF with a DRev virus (superinfection) (Fig. 5b) . It should be noted, however, that much higher levels of integration, reaching up to between 25 and 30 integrations per cell, were obtained when cells were exposed to the DRev viruses 2 h after the 1st-INF (Fig. 5b) , as compared with the 1.4 integrations per cell obtained under the same conditions following 2nd-INF with the wt HIV-1 strains (Fig. 5a ). The involvement of Rev in suppressing the level of integration when the 2nd-INF was performed between 4 and 288 h was further confirmed by the addition of INr peptides ( Supplementary Fig. S5 , available in JGV Online).
SIR is induced by de novo synthesized Rev
The possibility that SIR can be exerted by Rev molecules, which are delivered by the invading virus particles and not necessarily by newly synthesized molecules should be considered. Therefore, the effect of RNA-and proteinsynthesis inhibitors on the appearance of Rev and suppression of integration was studied. As can be seen when the 1st-INF and 2nd-INF were conducted with the INm (to ensure expression of only Rev-ear) and wt HIV, respectively, the addition of cycloheximide and actinomycin D significantly increased the degree of integration (compare results shown in Fig. 6a, b to Fig. 1a ) and completely blocked synthesis of Rev (Fig. 6c) . These results strongly indicate that the suppression of integration, as an indicator for the promotion of SIR, observed at an early stage of infection results from the appearance of newly synthesized Rev molecules. Furthermore, the possibility that the newly synthesized Rev is encoded by virusadsorbed cDNA molecules (see Lori et al., 1992) is eliminated by the results showing that AZT caused complete inhibition of the integration observed early on in infection, namely at 2-4 h after the 1st-INF (Fig. 6d) . The requirement for an active process of reverse transcription of the viral RNA is thus established. Obviously, the fact that the observed stimulatory effect of cycloheximide and actinomycin D (Fig. 6a, b) , as well as the inhibitory effect of AZT (Fig. 6d) , are transient is due to their short intracellular half lives (Du & Low, 2001; Jensen et al., 1998; Johnson, 2001) . It is worth noting that the integration levels observed following a single infection by a wt virus were also significantly stimulated by cycloheximide and actinomycin (Fig. 6e) , probably indicating that also in this case, integration is suppressed by newly synthesized Rev (Iyer et al., 2009; Levin et al., 2009a) . It should be mentioned that the appearance of newly assembled viruses as well as newly synthesized viral p24 was completely inhibited in the presence of these inhibitors (data not shown). 
Involvement of Rev in the regulation of integration events in synchronously infected cells
Generally, infection involves variation in the kinetics of virus adsorption, a process which may last for up to 4 h (Levin et al., 2009b) . Therefore, a single infection can be considered as a double-or even superinfection process within a relatively short period of time. This pseudo-superinfection process is likely to be avoided by using a synchronized infection system. It was therefore of interest to study whether Rev is also involved in regulation of integration following synchronized infection. A threefold increase was observed in the integration per cell following synchronized infection (see Methods) as compared with the integration obtained following a non-synchronized (regular) single infection (Fig. 7a) . Interestingly, as was observed following single (Levin et al., 2009a) or superinfection (Fig. 5a ), significantly higher integrations per cell were also obtained when synchronized infection was conducted with the DRev virus (Fig. 7b) . The observed integration levels were about twofold higher than those observed following a regular single infection (Fig. 7b) . As has been observed previously (Levin et al., 2009a (Levin et al., , 2010b , infection by the wt and DRev viruses resulted in the appearance of the same amount of viral cDNA (Fig. 7c) . However, the amount of viral cDNA obtained in synchronized infected cells was about twofold higher than that observed following non-synchronized infection (Fig. 7c) .
DISCUSSION
Resistance of already infected cells to HIV infection has been considered to be mainly due to downregulation of the host cell membrane's CD4 receptors (Potash & Volsky, 1998; Saha et al., 1999) . Downregulation of CD4 has been attributed to the expression of the viral Nef, Vpu and Env proteins (Wildum et al., 2006) . Although the involvement of the CD4 receptors in conferring resistance is still under debate, there appears to be general agreement regarding the existence of an additional CD4-independent mechanism that promotes SIR (Potash & Volsky, 1998; Wildum et al., 2006) . Moreover, the notion that interference with a second infection can be attributed to the presence of viral and not cellular encoded proteins is generally accepted (Nethe et al., 2005; Potash & Volsky, 1998) . The mechanism which is responsible for SIR in HIV-1-infected cells is of interest, particularly for the development of novel approaches to anti-HIV therapy. One of the approaches that could be developed based on the mechanism of SIR is to imitate the condition that restricts the 2nd-INF in noninfected cells in order to transform them to resistance for infection.
Here, the involvement of the HIV Rev protein in conferring SIR is suggested. Cells expressing Rev, from either unintegrated or integrated viral cDNA, are resistant to virus infection. These results are supported by our previous studies showing that transfected cells expressing the Rev protein are almost completely immune to infection by HIV-1 (Levin et al., 2009a (Levin et al., , 2010b . Our previous results (Levin et al., 2009a, b) , as well, show that integration of the viral cDNA into the host chromosomal DNA is regulated by the Rev protein via its interaction with the viral IN. The fact that formation of Rev-IN complexes confers inhibition of IN enzymic activity has been demonstrated under in vitro as well as in vivo conditions (Levin et al., 2009a, b) . Disruption of this complex, which can be achieved by peptides derived from IN that interact with Rev (the INrs) (Levin et al., 2009a, b) , resulted in reactivation of the viral IN activity allowing multiple integration of the HIV-1 cDNA (Levin et al., 2009a) .
Thus, the requirement of Rev for promoting SIR in infected cells can be inferred from two kinds of experiments. First, addition of INr peptides abolished resistance and resulted in stimulation of viral cDNA integration. Second, no resistance -as reflected by integrations per cell -was observed in the absence of Rev, particularly following double infection with DRev viruses. The fact that complete resistance can be promoted by merely the presence of Rev should be inferred from the results obtained following second infection with the VSV-g-coated virus, whose penetration into cells is independent of CD4 (Matlin et al., 1982) .
Our results may also indicate the contribution of a CD4-dependent mechanism to SIR, especially in the complete absence of Rev. Indeed a 50 % reduction in the integration values was obtained following infection with wt-coated DRev virus when compared to infection with VSV-g-coated DRev virus. Thus, our observations support previous indications (Potash & Volsky, 1998; Wildum et al., 2006) of the existence of CD4-dependent and -independent mechanisms conferring SIR. Both mechanisms necessitate the presence of actively expressed viral genes. The extent of SIR probably is regulated by two parameters: the degree to which viral encoded proteins (Nef, Vpu, Env and Rev) are expressed following the 1st-INF, and the m.o.i. of the 2nd-INF. Indeed, results in the present work show that the degree of Rev-induced SIR can be decreased by increasing the m.o.i. of the 2nd-INF.
Our results suggest an additional new aspect in the process of Rev-induced resistance. Almost the same degree of integration, on average 1-2 integrations per cell, was observed following double, super and single infection by the wt virus at viral titres between m.o.i.51 and 10. Similar to the case of double or superinfection, stimulation of virus integration was also observed, in the absence of Rev or in the presence of INrs, following a single infection (see also Levin et al., 2009a, b) . This is not necessarily surprising since in a certain respect, the single infection process may present the same features that characterize double infection. It has been well established that the same cell can interact with more than one virus particle and that the course of virus-cell adsorption may extend over a period of about 4 h (Levin et al., 2009b; Pannecouque et al., 2002) . Thus, the possibility of the first round of infection conferring, on a cellular level and due to de novo Rev synthesis, immunity to the second round of infection cannot be excluded. This might explain the stimulation of integration observed previously (Levin et al., 2009a, b) and in the present work by the addition of the INrs and in the absence of Rev following a single infection of cultured cells. If indeed this is the case, then no stimulation of integration should be observed in the absence of Rev following synchronized infection. Furthermore, such infection should result in a high level of integration when a wt virus is added. Indeed, the integration levels observed following synchronized infection were higher than those obtained following regular (not synchronized) single infection by the wt virus. However, synchronized infection with a DRev virus, i.e. in the absence of Rev, resulted in significantly higher integration levels than synchronized infection by the wt virus. This may indicate that, in addition to the already established inhibition of HIV IN activity by Rev, an additional -as yet non-elucidated -effect may be exerted by Rev, which restricts the level of integration and thus infection in HIV-1-infected cells. It should be noted that the speed with which the infection occurs after absorption can also differ from one entry event to the other. Attempts to reveal if indeed such a mechanism exists are under way in our laboratory. In any event, Rev-induced interference in virus infection as reflected by inhibition of cDNA integration appears to be a more general phenomenon. + cells were generated by transfection of HEK293T cells (Cullen, 1987; Levin et al., 2010a) . The cells were incubated at 37 uC in a 5 % CO 2 atmosphere. All media were supplemented with 10 % (v/v) fetal calf serum, 0.3 g L-glutamine l 21 , 100 U penicillin ml 21 and 100 U streptomycin ml 21 (Biological Industries). Sup-T1/TL3 cells, a generous gift from Professor Poeschla (Mayo Foundation), were grown as described previously (Llano et al., 2006) .
Viruses. Wt HIV-1 [HXB2 (Ratner et al., 1985) ] as well as the IN mutant D64N D116N (Nakajima et al., 2001) were generated by transfection of HEK293T cells (Cullen, 1987) with the viruscontaining plasmid or co-transfection with a plasmid containing VSV-g (Levin et al., 2009b) . DRev HIV (Verhoef et al., 1997) was generated by transfection of Rev10 + cells with pLAIY47H2 (Cullen, 1987) . Viruses were harvested and stored as described previously (Levin et al., 2009b) . The pLAIY47H2 (Verhoef et al., 1997) Virus stock titration and normalization. Quantitative titration of HIV-1 was carried out using the MAGI assay, as described by Kimpton & Emerman (1992) . Briefly, TZM-b1 cells were grown in 96-well plates at 1610 4 cells per well. The cells were infected with 50 ml serially diluted virus (wt or DRev HIV-1) as described previously (Kimpton & Emerman, 1992) . Cultured cells were fixed (2 days p.i.) and b-galactosidase was estimated exactly as described previously (Kimpton & Emerman, 1992) . Blue cells were counted under a light microscope at 6200 magnification. In the case of IN mutant viruses (D64N D116N) the amount of viral RNA was estimated by real-time reverse transcription PCR as described in Pizzato et al. (2009) . This was also performed on the other HIV-1 viruses and was used to normalize the titre of the IN mutant virus. Virus stocks were concentrated by ultracentrifugation (25 000 r.p.m.
at 15 uC for 105 min) using a Beckman SW28 rotor (Reiser, 2000) and then virus titre was determined as described above.
Peptide synthesis, labelling and purification. Peptides were synthesized on an Applied Biosystems (ABI) 433A peptide synthesizer. For cellular-uptake studies, the peptides were labelled with fluorescein at their N terminus . Peptides were also labelled with Trp at their N terminus for UV spectroscopy. Peptide purification was performed on a Gilson HPLC using a reverse-phase C8 semi-preparative column (ACE; Advanced Chromatography Technologies) with a gradient of 5-60 % acetonitrile in water. Peptide concentrations were determined using a UV spectrophotometer (Shimadzu Kyoto) as described previously (Köhler et al., 1989) .
Infection of cultured lymphocytes with HIV-1. Cultured lymphocytes (1610 5 ) were centrifuged for 5 min at 500 g and after removal of the supernatant, the cells were resuspended in 0.2-0.5 ml RPMI 1640 medium containing virus at different m.o.i. Following absorption for 2 h at 37 uC, the cells were washed to remove unbound virus and then incubated at the same temperature for up to 12 days . In the case of 2nd-INF, cells were infected with the indicated viruses at different m.o.i. at the indicated times after the first infection. For synchronized infection, virus adsorption was carried out for 2 h at 4 uC then cells were washed as described above and further incubated at 37 uC as described previously (Kopetzki et al., 2008) .
Quantitative analysis of the copy numbers of HIV-1 DNA integrated into the host cellular genome. Cells (samples of 200 ml) were removed 24 h post-2nd-INF, washed three times with PBS, and the integration levels of the viral cDNA were estimated exactly as described previously . Briefly, integrated HIV-1 sequences were amplified by two PCR replication steps using the HIV-1 LTR-specific primer (LTR-TAG-F 59-AT-GCCACGTAAGCGAAACTCTGGCTAACTAGGGAACCCACTG-39) and Alu-targeting primers (first-Alu-F 59-AGCCTCCCGAGTAG-CTGGGA-39 and first-Alu-R 59-TTACAGGCATGAGCCACCG-39) (Yamamoto et al., 2006) . During the second-round PCR, the firstround PCR product could be specifically amplified by using the tagspecific primer (tag-F 59-ATGCCACGTAAGCGAAACTC-39) and the LTR primer (LTR-R 59-AGGCAAGCTTTATTGAGGCTTAAG-39) designed by PrimerExpress (Applied Biosystems) using default settings. The standard linear curve was in the range of 5 ng to 0.25 fg (R50.99). DNA samples were assayed in quadruplicates of each sample.
Quantitative analysis of the copy numbers of total HIV-1 DNA.
Total viral DNA was estimated using SYBR green real-time quantitative PCR 12 h p.i., exactly as described by Casabianca et al. (2007) . Briefly, DNA samples (1 mg DNA) were added to 95 ml containing 16 Hot-Rescue Real-time PCR kit-SG (Diatheva s.r.l.) and 100 nM of each primer-binding site primer: F5 (59 primer, 59-TAGCAGTGGCGCCCGA-39) and R5 (39 primer, 59-TCTCTCTCC-TTCTAGCCTCCGC-39). All amplification reactions were carried out using an ABI Prism 7700 Sequence Detection System (Applied Biosystems): one cycle at 95 uC for 10 min, followed by 45 cycles of 15 s at 95 uC and 35 s at 68 uC. In each PCR run, three replicates were performed.
Estimation of inhibitor effects on SIR. Inhibitors were added 1 h before the 1st-INF. The final concentration of each inhibitor was: 2 mM AZT, 5 mg actinomycin D ml 21 and 50 mg cycloheximide ml
21
.
Western blot analysis. Cells were infected with the indicated viruses at an m.o.i.510 and harvested at different times p.i., washed three times with PBS and lysed by the addition of PBS containing 1 % (v/v) Triton X-100. The lysate was subjected to SDS-PAGE [using E-PAGE When peptides were used, cells were incubated with 150 mM of the indicated peptide for 2 h prior to infection.
All the experiments described in the present work have been repeated at least three times and the difference between the results never exceeded±10 %.
